{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:07:25Z","timestamp":1789168045868,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejphar.2019.05.030","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:06:04Z","timestamp":1558091164000},"page":"172401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Dexmedetomidine effects in different experimental sepsis in vivo models"],"prefix":"10.1016","volume":"856","author":[{"given":"Ioannis","family":"Dardalas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Stamoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Malliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Tsaousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Aidoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Grosomanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Milonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kouvelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssa","family":"Pourzitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.05.030_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1179\/joc.1999.11.6.536","article-title":"Sepsis and septic shock: pro-inflammatory or anti-inflammatory state?","volume":"11","author":"Antonelli","year":"1999","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejphar.2019.05.030_bib3","volume":"vol. 1","author":"Bennett","year":"2014"},{"key":"10.1016\/j.ejphar.2019.05.030_bib4","first-page":"10752","article-title":"Activation of alpha2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2019.05.030_bib5","first-page":"1472","article-title":"[Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury]","volume":"35","author":"Chen","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2019.05.030_bib6","article-title":"Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats","volume":"12","author":"Cheng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.05.030_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jocn.2004.06.008","article-title":"The role of alpha2-agonists in neurosurgery","volume":"12","author":"Cormack","year":"2005","journal-title":"J. Clin. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2019.05.030_bib8","first-page":"ii11","article-title":"Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective)","volume":"66","author":"Daniels","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2019.05.030_bib9","series-title":"Sepsis with Acute Organ Dysfunction. NY","author":"Ely","year":"2005"},{"key":"10.1016\/j.ejphar.2019.05.030_bib10","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/CCM.0b013e3182986248","article-title":"Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study","volume":"41","author":"Geloen","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-016-1419-x","article-title":"Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock","volume":"20","author":"Hernandez","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2019.05.030_bib12","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/cc7709","article-title":"Central sympatholytics prolong survival in experimental sepsis","volume":"13","author":"Hofer","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2019.05.030_bib13","first-page":"5245","article-title":"Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway","volume":"9","author":"Hu","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ejphar.2019.05.030_bib14","article-title":"Renal sympathetic nerve activity and vascular reactivity to phenylephrine after lipopolysaccharide administration in conscious rats","volume":"5","author":"Julien","year":"2017","journal-title":"Phys. Rep."},{"key":"10.1016\/j.ejphar.2019.05.030_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biopha.2018.06.059","article-title":"Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an alpha7 nAChR-dependent pathway","volume":"106","author":"Kang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.05.030_bib54","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/01586154-201305000-00028","article-title":"Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro","volume":"74","author":"Kawasaki","year":"2013","journal-title":"J Trauma Acute Care Surg."},{"key":"10.1016\/j.ejphar.2019.05.030_bib55","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.05.030_bib16","doi-asserted-by":"crossref","first-page":"292687","DOI":"10.1155\/2013\/292687","article-title":"The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis","volume":"2013","author":"Koca","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejphar.2019.05.030_bib17","first-page":"5040","article-title":"Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice","volume":"9","author":"Kong","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ejphar.2019.05.030_bib18","first-page":"987","article-title":"[Effect of dexmedetomidine on high-mobility group box 1 protein in rats with sepsis]","volume":"40","author":"Li","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ejphar.2019.05.030_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s40064-015-1598-y","article-title":"The role of spleen in the treatment of experimental lipopolysaccharide-induced sepsis with dexmedetomidine","volume":"4","author":"Liu","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ejphar.2019.05.030_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.intimp.2016.04.003","article-title":"Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway","volume":"35","author":"Liu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2019.05.030_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/nyas.12444","article-title":"Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies","volume":"1323","author":"Lyle","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.05.030_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5847\/wjem.j.1920-8642.2018.01.009","article-title":"Dose-related effects of dexmedetomidine on immunomodulation and mortality to septic shock in rats","volume":"9","author":"Ma","year":"2018","journal-title":"World J. Emerg. Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0885066613510874","article-title":"A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes","volume":"30","author":"MacLaren","year":"2015","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.ejphar.2019.05.030_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/ALN.0000000000000491","article-title":"Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis","volume":"122","author":"Miranda","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2019.05.030_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/01616412.2017.1281197","article-title":"Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice","volume":"39","author":"Ning","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2019.05.030_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1213\/00000539-199902000-00042","article-title":"The effects of clonidine and dexmedetomidine on human neutrophil functions","volume":"88","author":"Nishina","year":"1999","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2019.05.030_bib29","article-title":"Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials","volume":"8","author":"Pasin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.05.030_bib30","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc8012","article-title":"Sedation improves early outcome in severely septic Sprague Dawley rats","volume":"13","author":"Qiao","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2019.05.030_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.05.001","article-title":"Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model","volume":"204","author":"Qiu","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.05.030_bib32","first-page":"108","article-title":"The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study","volume":"16","author":"Sezer","year":"2010","journal-title":"Ulus. Travma Acil Cerrahi Derg."},{"key":"10.1016\/j.ejphar.2019.05.030_bib33","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1111\/bph.12829","article-title":"Therapeutic interventions in sepsis: current and anticipated pharmacological agents","volume":"171","author":"Shukla","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.05.030_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.05.030_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7861\/clinmedicine.12-3-276","article-title":"Sepsis: recognition and treatment","volume":"12","author":"Soong","year":"2012","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/br.2015.427","article-title":"Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats","volume":"3","author":"Tan","year":"2015","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.ejphar.2019.05.030_bib37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.CCM.0000128579.84228.2A","article-title":"Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats","volume":"32","author":"Taniguchi","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00540-008-0611-9","article-title":"Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats","volume":"22","author":"Taniguchi","year":"2008","journal-title":"J. Anesth."},{"key":"10.1016\/j.ejphar.2019.05.030_bib40","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/tox.22011","article-title":"Different cellular responses of dexmedetomidine at infected site and peripheral blood of emdotoxemic BALB\/c mice","volume":"30","author":"Wu","year":"2015","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ejphar.2019.05.030_bib41","first-page":"562154","article-title":"Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4\/NF-kappaB pathway","author":"Wu","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2019.05.030_bib42","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s10753-014-9906-1","article-title":"Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"37","author":"Xiang","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2019.05.030_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00011-013-0604-5","article-title":"Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice","volume":"62","author":"Xu","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2019.05.030_bib44","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.jss.2010.02.020","article-title":"Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats","volume":"167","author":"Yang","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2019.05.030_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001135","article-title":"Effects of dexmedetomidine on intestinal microcirculation and intestinal epithelial barrier in endotoxemic rats","volume":"125","author":"Yeh","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2019.05.030_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jss.2015.05.029","article-title":"Different effects of propofol and dexmedetomidine on preload dependency in endotoxemic shock with norepinephrine infusion","volume":"198","author":"Yu","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2019.05.030_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1871529X15666150108114810","article-title":"Sepsis pathophysiology and anesthetic consideration","volume":"15","author":"Yuki","year":"2015","journal-title":"Cardiovasc. Haematol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2019.05.030_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10517-018-4190-y","article-title":"Combined effect of NF-kappaB inhibitor and beta2-adrenoreceptor agonist on mouse mortality and blood concentration of proinflammatory cytokines in sepsis","volume":"165","author":"Zabrodskii","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2019.05.030_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12871-015-0042-8","article-title":"The effect of dexmedetomidine on inflammatory response of septic rats","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ejphar.2019.05.030_bib50","first-page":"127","article-title":"[Role of alpha7 nicotinic acetylcholine receptor in attenuation of endotoxin induced delirium with dexmedetomidine in mice]","volume":"28","author":"Zhang","year":"2016","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ejphar.2019.05.030_bib51","article-title":"Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-kappaB pathway","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.05.030_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/mmr.2016.6050","article-title":"Dexmedetomidine may upregulate the expression of caveolin1 in lung tissues of rats with sepsis and improve the shortterm outcome","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2019.05.030_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biopha.2018.04.150","article-title":"Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system","volume":"103","author":"Zhao","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:59Z","timestamp":1757975279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919303449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":54,"alternative-id":["S0014299919303449"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.05.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine effects in different experimental sepsis in vivo models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172401"}}